Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Published in: Journal of Nuclear Cardiology 2/2013

01-04-2013 | ASNC 2013 Education Calendar

ASNC 2013 Education Calendar

Published in: Journal of Nuclear Cardiology | Issue 2/2013

Login to get access

Excerpt

The American Society of Nuclear Cardiology (ASNC) is an accredited provider of continuing education for physicians and technologists. ASNC provides outstanding educational programming for the nuclear cardiology community, including interactive workshops, Board Prep review courses, webinars, local learning groups, and specific programs for online users. For more information, visit: www.​asnc.​org. …
Metadata
Title
ASNC 2013 Education Calendar
Publication date
01-04-2013
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 2/2013
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-013-9687-1

Other articles of this Issue 2/2013

Journal of Nuclear Cardiology 2/2013 Go to the issue

Letter to the Editor

Letter to the editor for prognosis in the era of comparative effectiveness research

Editorial

Off-label, but on-target: Use of regadenoson with exercise

Original Article

Evaluation of right ventricular volume and ejection fraction by gated 18F-FDG PET in patients with pulmonary hypertension: Comparison with cardiac MRI and CT

Review Article

The role of F18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis

Original Article

Regadenoson pharmacologic stress for myocardial perfusion imaging: A three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise

Original Article

A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: A randomized controlled trial

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits